O	0	8	Syndecan	Syndecan	NN	B-NP
O	8	9	-	-	HYPH	B-NP
O	9	10	1	1	CD	I-NP
O	11	21	expression	expression	NN	I-NP
O	22	24	in	in	IN	B-PP
B-Cell	25	32	mammary	mammary	JJ	B-NP
I-Cell	33	43	epithelial	epithelial	JJ	I-NP
I-Cell	44	49	tumor	tumor	NN	I-NP
I-Cell	50	55	cells	cell	NNS	I-NP
O	56	58	is	be	VBZ	B-VP
O	59	60	E	E	NN	B-NP
O	60	61	-	-	HYPH	B-NP
O	61	69	cadherin	cadherin	NN	I-NP
O	69	70	-	-	HYPH	B-VP
O	70	79	dependent	dependent	JJ	B-ADJP
O	79	80	.	.	.	O

O	82	83	E	E	NN	B-NP
O	83	84	-	-	HYPH	I-NP
O	84	92	cadherin	cadherin	NN	I-NP
O	93	95	is	be	VBZ	B-VP
O	96	97	a	a	DT	B-NP
O	98	100	Ca	Ca	NN	I-NP
O	100	101	(	(	(	O
O	101	102	2	2	CD	B-NP
O	102	103	+	+	SYM	O
O	103	104	)	)	)	O
O	104	105	-	-	HYPH	O
O	105	114	dependent	dependent	JJ	B-NP
B-Cell	115	119	cell	cell	NN	I-NP
O	119	120	-	-	HYPH	B-NP
B-Cell	120	124	cell	cell	NN	I-NP
O	125	133	adhesion	adhesion	NN	I-NP
O	134	142	molecule	molecule	NN	I-NP
O	142	143	,	,	,	O
O	144	149	which	which	WDT	B-NP
O	150	152	is	be	VBZ	B-VP
O	153	159	mainly	mainly	RB	I-VP
O	160	169	expressed	express	VBN	I-VP
O	170	172	in	in	IN	B-PP
B-Cell	173	183	epithelial	epithelial	JJ	B-NP
I-Cell	184	189	cells	cell	NNS	I-NP
O	189	190	.	.	.	O

O	191	197	Recent	Recent	JJ	B-NP
O	198	205	studies	study	NNS	I-NP
O	206	210	have	have	VBP	B-VP
O	211	216	shown	show	VBN	I-VP
O	217	221	that	that	IN	B-SBAR
O	222	223	E	E	NN	B-NP
O	223	224	-	-	HYPH	O
O	224	232	cadherin	cadherin	NN	B-NP
O	233	236	has	have	VBZ	B-VP
O	237	239	an	an	DT	B-NP
O	240	249	important	important	JJ	I-NP
O	250	254	role	role	NN	I-NP
O	255	257	as	as	IN	B-PP
O	258	260	an	an	DT	B-NP
O	261	269	invasion	invasion	NN	I-NP
O	270	280	suppressor	suppressor	NN	I-NP
O	281	289	molecule	molecule	NN	I-NP
O	290	292	in	in	IN	B-PP
B-Cell	293	303	epithelial	epithelial	JJ	B-NP
I-Cell	304	309	tumor	tumor	NN	I-NP
I-Cell	310	315	cells	cell	NNS	I-NP
O	315	316	.	.	.	O

O	317	325	Syndecan	Syndecan	NN	B-NP
O	325	326	-	-	HYPH	B-NP
O	326	327	1	1	CD	I-NP
O	328	330	is	be	VBZ	B-VP
O	331	332	a	a	DT	B-NP
B-Cellular_component	333	337	cell	cell	NN	I-NP
I-Cellular_component	338	345	surface	surface	NN	I-NP
O	346	358	proteoglycan	proteoglycan	NN	I-NP
O	359	363	that	that	WDT	B-NP
O	364	367	has	have	VBZ	B-VP
O	368	372	been	be	VBN	I-VP
O	373	383	implicated	implicate	VBN	I-VP
O	384	386	in	in	IN	B-PP
O	387	388	a	a	DT	B-NP
O	389	395	number	number	NN	I-NP
O	396	398	of	of	IN	B-PP
B-Cell	399	407	cellular	cellular	JJ	B-NP
O	408	417	functions	function	NNS	I-NP
O	418	427	including	include	VBG	B-PP
B-Cell	428	432	cell	cell	NN	B-NP
O	432	433	-	-	HYPH	I-NP
B-Cell	433	437	cell	cell	NN	I-NP
O	438	446	adhesion	adhesion	NN	I-NP
O	446	447	,	,	,	O
B-Cell	448	452	cell	cell	NN	B-NP
O	452	453	-	-	HYPH	B-NP
B-Cellular_component	453	459	matrix	matrix	NN	I-NP
O	460	469	anchorage	anchorage	NN	I-NP
O	470	473	and	and	CC	O
O	474	480	growth	growth	NN	B-NP
O	481	487	factor	factor	NN	I-NP
O	488	500	presentation	presentation	NN	I-NP
O	501	504	for	for	IN	B-PP
O	505	515	signalling	signalling	NN	B-NP
O	516	525	receptors	receptor	NNS	I-NP
O	525	526	.	.	.	O

O	527	530	Its	Its	PRP$	B-NP
O	531	542	suppression	suppression	NN	I-NP
O	543	546	has	have	VBZ	B-VP
O	547	551	also	also	RB	I-VP
O	552	556	been	be	VBN	I-VP
O	557	562	shown	show	VBN	I-VP
O	563	565	to	to	TO	I-VP
O	566	568	be	be	VB	I-VP
O	569	579	associated	associate	VBN	I-VP
O	580	584	with	with	IN	B-PP
O	585	594	malignant	malignant	JJ	B-NP
O	595	609	transformation	transformation	NN	I-NP
O	610	612	of	of	IN	B-PP
B-Cell	613	623	epithelial	epithelial	JJ	B-NP
I-Cell	624	629	cells	cell	NNS	I-NP
O	629	630	.	.	.	O

O	631	633	In	In	IN	B-SBAR
O	634	639	order	order	NN	O
O	640	642	to	to	TO	B-VP
O	643	649	better	well	RBR	I-VP
O	650	660	understand	understand	VB	I-VP
O	661	664	the	the	DT	B-NP
O	665	676	coordinated	coordinate	VBN	I-NP
O	677	687	regulation	regulation	NN	I-NP
O	688	690	of	of	IN	B-PP
B-Cell	691	695	cell	cell	NN	B-NP
O	695	696	-	-	HYPH	B-NP
B-Cell	696	700	cell	cell	NN	I-NP
O	701	704	and	and	CC	I-NP
B-Cell	705	709	cell	cell	NN	I-NP
O	709	710	-	-	HYPH	B-NP
B-Cellular_component	710	716	matrix	matrix	NN	I-NP
O	717	729	interactions	interaction	NNS	I-NP
O	730	736	during	during	IN	B-PP
O	737	746	malignant	malignant	JJ	B-NP
O	747	761	transformation	transformation	NN	I-NP
O	761	762	,	,	,	O
O	763	765	we	we	PRP	B-NP
O	766	770	have	have	VBP	B-VP
O	771	778	studied	study	VBN	I-VP
O	779	782	the	the	DT	B-NP
O	783	793	expression	expression	NN	I-NP
O	794	796	of	of	IN	B-PP
O	797	805	syndecan	syndecan	NN	B-NP
O	805	806	-	-	HYPH	B-NP
O	806	807	1	1	CD	I-NP
O	808	810	in	in	IN	B-PP
B-Cell	811	820	malignant	malignant	JJ	B-NP
I-Cell	821	828	mammary	mammary	JJ	I-NP
I-Cell	829	834	tumor	tumor	NN	I-NP
I-Cell	835	840	cells	cell	NNS	I-NP
O	841	852	genetically	genetically	RB	B-VP
O	853	864	manipulated	manipulate	VBN	I-VP
O	865	868	for	for	IN	B-PP
O	869	870	E	E	NN	B-NP
O	870	871	-	-	HYPH	O
O	871	879	cadherin	cadherin	NN	B-NP
O	880	890	expression	expression	NN	I-NP
O	890	891	.	.	.	O

O	892	894	In	In	IN	B-PP
O	895	903	invasive	invasive	JJ	B-NP
B-Cell	904	906	NM	NM	NN	I-NP
I-Cell	906	907	-	-	HYPH	B-NP
I-Cell	907	908	e	e	NN	I-NP
I-Cell	908	909	-	-	HYPH	B-NP
I-Cell	909	912	ras	ras	NN	I-NP
I-Cell	912	913	-	-	HYPH	B-NP
I-Cell	913	917	MAC1	MAC1	NN	I-NP
I-Cell	918	923	cells	cell	NNS	I-NP
O	923	924	,	,	,	O
O	925	930	where	where	WRB	B-ADVP
O	931	932	E	E	NN	B-NP
O	932	933	-	-	HYPH	O
O	933	941	cadherin	cadherin	NN	B-NP
O	942	945	was	be	VBD	B-VP
O	946	955	partially	partially	RB	I-VP
O	956	969	downregulated	downregulate	VBN	I-VP
O	970	972	by	by	IN	B-PP
O	973	981	specific	specific	JJ	B-NP
O	982	991	antisense	antisense	JJ	I-NP
O	992	995	RNA	RNA	NN	I-NP
O	995	996	,	,	,	O
O	997	1005	syndecan	syndecan	NN	B-NP
O	1005	1006	-	-	HYPH	O
O	1006	1007	1	1	CD	B-NP
O	1008	1018	expression	expression	NN	I-NP
O	1019	1022	was	be	VBD	B-VP
O	1023	1033	suppressed	suppress	VBN	I-VP
O	1033	1034	.	.	.	O

O	1035	1046	Furthermore	Furthermore	RB	B-ADVP
O	1046	1047	,	,	,	O
O	1048	1060	transfection	transfection	NN	B-NP
O	1061	1063	of	of	IN	B-PP
O	1064	1065	E	E	NN	B-NP
O	1065	1066	-	-	HYPH	B-NP
O	1066	1074	cadherin	cadherin	NN	I-NP
O	1075	1079	cDNA	cDNA	NN	I-NP
O	1080	1084	into	into	IN	B-PP
O	1085	1093	invasive	invasive	JJ	B-NP
B-Cell	1094	1096	NM	NM	NN	I-NP
I-Cell	1096	1097	-	-	HYPH	B-NP
I-Cell	1097	1098	f	f	NN	I-NP
I-Cell	1098	1099	-	-	HYPH	B-NP
I-Cell	1099	1102	ras	ras	NN	I-NP
I-Cell	1102	1103	-	-	HYPH	I-NP
I-Cell	1103	1105	TD	TD	NN	I-NP
I-Cell	1106	1111	cells	cell	NNS	I-NP
O	1112	1120	resulted	result	VBD	B-VP
O	1121	1123	in	in	IN	B-PP
O	1124	1127	the	the	DT	B-NP
O	1128	1140	upregulation	upregulation	NN	I-NP
O	1141	1143	of	of	IN	B-PP
O	1144	1152	syndecan	syndecan	NN	B-NP
O	1152	1153	-	-	HYPH	B-NP
O	1153	1154	1	1	CD	I-NP
O	1155	1165	expression	expression	NN	I-NP
O	1166	1168	in	in	IN	B-PP
O	1169	1180	association	association	NN	B-NP
O	1181	1185	with	with	IN	B-PP
O	1186	1195	decreased	decrease	VBN	B-NP
O	1196	1208	invasiveness	invasiveness	NN	I-NP
O	1208	1209	.	.	.	O

O	1210	1212	In	In	IN	B-PP
O	1213	1217	both	both	DT	B-NP
O	1218	1223	cases	case	NNS	I-NP
O	1223	1224	,	,	,	O
O	1225	1235	regulation	regulation	NN	B-NP
O	1236	1238	of	of	IN	B-PP
O	1239	1247	syndecan	syndecan	NN	B-NP
O	1247	1248	-	-	HYPH	B-NP
O	1248	1249	1	1	CD	I-NP
O	1250	1258	occurred	occur	VBD	B-VP
O	1259	1263	post	post	AFX	O
O	1263	1264	-	-	HYPH	O
O	1264	1281	transcriptionally	transcriptionally	RB	B-ADVP
O	1281	1282	,	,	,	O
O	1283	1288	since	since	IN	B-SBAR
O	1289	1297	syndecan	syndecan	NN	B-NP
O	1297	1298	-	-	HYPH	B-NP
O	1298	1299	1	1	CD	I-NP
O	1300	1304	mRNA	mRNA	NN	I-NP
O	1305	1311	levels	level	NNS	I-NP
O	1312	1320	remained	remain	VBD	B-VP
O	1321	1330	unchanged	unchanged	JJ	B-ADJP
O	1330	1331	.	.	.	O

O	1332	1339	Instead	Instead	RB	B-ADVP
O	1339	1340	,	,	,	O
O	1341	1342	a	a	DT	B-NP
O	1343	1356	translational	translational	JJ	I-NP
O	1357	1367	regulation	regulation	NN	I-NP
O	1368	1370	is	be	VBZ	B-VP
O	1371	1380	suggested	suggest	VBN	I-VP
O	1380	1381	,	,	,	O
O	1382	1387	since	since	IN	B-SBAR
O	1388	1396	syndecan	syndecan	NN	B-NP
O	1396	1397	-	-	HYPH	B-NP
O	1397	1398	1	1	CD	I-NP
O	1399	1403	core	core	NN	I-NP
O	1404	1411	protein	protein	NN	I-NP
O	1412	1421	synthesis	synthesis	NN	I-NP
O	1422	1425	was	be	VBD	B-VP
O	1426	1427	E	E	NN	B-NP
O	1427	1428	-	-	HYPH	B-NP
O	1428	1436	cadherin	cadherin	NN	I-NP
O	1437	1446	dependent	dependent	JJ	B-ADJP
O	1446	1447	.	.	.	O

O	1448	1455	Another	Another	DT	B-NP
B-Cell	1456	1460	cell	cell	NN	I-NP
O	1461	1469	adhesion	adhesion	NN	I-NP
O	1470	1477	protein	protein	NN	I-NP
O	1477	1478	,	,	,	O
O	1479	1483	beta	beta	SYM	B-NP
O	1484	1485	1	1	CD	I-NP
O	1485	1486	-	-	HYPH	I-NP
O	1486	1494	integrin	integrin	NN	I-NP
O	1495	1498	was	be	VBD	B-VP
O	1499	1502	not	not	RB	I-VP
O	1503	1511	affected	affect	VBN	I-VP
O	1512	1514	by	by	IN	B-PP
O	1515	1516	E	E	NN	B-NP
O	1516	1517	-	-	HYPH	O
O	1517	1525	cadherin	cadherin	NN	B-NP
O	1526	1536	expression	expression	NN	I-NP
O	1536	1537	.	.	.	O

O	1538	1541	The	The	DT	B-NP
O	1542	1546	data	datum	NNS	I-NP
O	1547	1554	provide	provide	VBP	B-VP
O	1555	1557	an	an	DT	B-NP
O	1558	1565	example	example	NN	I-NP
O	1566	1568	of	of	IN	B-PP
O	1569	1580	coordinated	coordinate	VBN	B-NP
O	1581	1588	changes	change	NNS	I-NP
O	1589	1591	in	in	IN	B-PP
O	1592	1595	the	the	DT	B-NP
O	1596	1606	expression	expression	NN	I-NP
O	1607	1609	of	of	IN	B-PP
O	1610	1613	two	two	CD	B-NP
B-Cell	1614	1618	cell	cell	NN	I-NP
O	1619	1627	adhesion	adhesion	NN	I-NP
O	1628	1637	molecules	molecule	NNS	I-NP
O	1637	1638	,	,	,	O
O	1639	1647	syndecan	syndecan	NN	B-NP
O	1647	1648	-	-	HYPH	B-NP
O	1648	1649	1	1	CD	I-NP
O	1650	1653	and	and	CC	I-NP
O	1654	1655	E	E	NN	I-NP
O	1655	1656	-	-	HYPH	B-NP
O	1656	1664	cadherin	cadherin	NN	I-NP
O	1665	1671	during	during	IN	B-PP
B-Cell	1672	1682	epithelial	epithelial	JJ	B-NP
I-Cell	1683	1687	cell	cell	NN	I-NP
O	1688	1702	transformation	transformation	NN	I-NP
O	1702	1703	.	.	.	O

